Anticoagulant Treatment Regimens in Patients With Covid‐19: A Meta‐Analysis

Coronavirus disease 2019 (COVID‐19) is associated with a hypercoagulable state. It has been hypothesized that higher‐dose anticoagulation, including therapeutic‐dose and intermediate‐dose anticoagulation, is superior to prophylactic‐dose anticoagulation in the treatment of COVID‐19. This meta‐analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Jorda, Anselm, Siller‐Matula, Jolanta M., Zeitlinger, Markus, Jilma, Bernd, Gelbenegger, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015466/
https://www.ncbi.nlm.nih.gov/pubmed/34862791
http://dx.doi.org/10.1002/cpt.2504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015466/
https://www.ncbi.nlm.nih.gov/pubmed/34862791
http://dx.doi.org/10.1002/cpt.2504

Ejemplares similares